Abstract |
This study tested the effect of a new gastrin receptor antagonist, CR2945, on colorectal cancer induced by 1,2-dimethylhydrazine ( DMH) in mice. 75 CD1 male mice were divided into 3 groups: group 1 received 1 weekly injection of 20 mg/kg of DMH and 2 daily intraperitoneal injections of 0.5 ml of NaCl 0.9% solution for 5 weeks; groups 2 and 3 received the same weekly dose of DMH and 2 daily injections of CR2945 at the respective doses of 2.5 and 7.5 mg/kg for 5 weeks. The animals were sacrificed 25 and 38 weeks after the first injection. No tumours were found at the 25th week. A lower cancer frequency (4%) was observed in treated animals compared to controls (37.4%) at the 38th week (p = 0.002). These data show that CR2945 could prevent chemically induced colon cancer development in mice.
|
Authors | M G Fontana, F Donato, V Villanacci, M Ghirardi, D Moneghini, E Di Betta, B Salerni |
Journal | European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes
(Eur Surg Res)
Vol. 31
Issue 5
Pg. 406-11
( 1999)
ISSN: 0014-312X [Print] Switzerland |
PMID | 10529554
(Publication Type: Journal Article)
|
Chemical References |
- CR 2945
- Carcinogens
- Receptors, Cholecystokinin
- Benzodiazepines
- 1,2-Dimethylhydrazine
|
Topics |
- 1,2-Dimethylhydrazine
- Adenocarcinoma
(chemically induced, epidemiology, pathology, prevention & control)
- Adenoma
(chemically induced, epidemiology, pathology, prevention & control)
- Animals
- Benzodiazepines
(pharmacology)
- Carcinogens
- Colorectal Neoplasms
(chemically induced, epidemiology, pathology, prevention & control)
- Incidence
- Male
- Mice
- Mice, Inbred Strains
- Receptors, Cholecystokinin
(antagonists & inhibitors)
|